Skip to main content

MoneyWorks4Me

Hikal informs about Outcome of Board Meeting

06 Jun 2014 Evaluate

Hikal has informed that the Board of Directors of the Company at its meeting held on May 06, 2014, has appointed Professor Dr. Axel Kleemann as an Additional Director u/s 149 of the Companies Act, 2013.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1912.35
Dr. Reddys Labs. 1392.00
Cipla 1408.10
Lupin 2023.65
Zydus Lifesciences 1206.95
View more..